Smoking Surges as Injection Drug Use Declines in U.S. Fentanyl Crisis

The landscape of drug use in the United States is shifting dramatically, as smoking opioids becomes more prevalent than injecting them. This change, particularly notable in regions heavily impacted by the fentanyl epidemic, reflects a significant transformation in user behavior aimed at reducing health risks.

Megan Merrill, a recovery advocate from New Hampshire, illustrates this trend as she distributes harm reduction supplies to vulnerable populations. On a recent hike, she navigated challenging terrain to deliver essential items, including sterile syringes and glass pipes. Her focus was clear: smoking can mitigate the health risks associated with injection drug use, such as infections and skin abscesses. “There’s less chance of you overdosing if you’re smoking than if you’re injecting,” Merrill stated while emphasizing the benefits of harm reduction.

As the opioid crisis evolves, the shift from injecting to smoking has occurred organically, particularly since the onset of the Covid-19 pandemic. Once a behavior more common in the West, smoking opioids has expanded to the East Coast, especially in cities like Philadelphia. The transition away from injection is largely attributed to the changing nature of the illicit drug supply, where strong synthetic opioids like fentanyl have become more accessible and dominant.

Health Risks and Harm Reduction Strategies

The increasing preference for smoking opioids is also linked to the dangers associated with injection. The presence of xylazine, a potent animal tranquilizer, has been particularly concerning, as it can cause severe skin wounds and increase health complications. As a result, many users are opting for smoking to avoid the risks of injection, which include exposure to blood-borne viruses like hepatitis C and HIV.

According to Caty Simon, a representative from the National Survivors Union, the shift is indicative of a broader, positive change in drug use behavior. “One of the basic mottos of harm reduction is ‘any positive change,’” she explained. “Substituting injection for smoking is a self-protective gesture.”

Research indicates that individuals who smoke drugs may be as much as 30% less likely to experience an overdose compared to those who inject. Experts believe that smoking not only reduces the risk of infectious diseases but also minimizes the potential for severe overdoses associated with needle use.

The Role of Harm Reduction Organizations

Harm reduction organizations across the United States are responding to this trend by adapting their services. Initiatives now include distributing smoking supplies such as foil and glass pipes, alongside traditional syringe exchanges. Smoke Works, a Massachusetts-based organization, has reported a significant increase in the demand for smoking supplies, with many clients opting for pipes over needles.

In a notable pilot program, Smoke Works found that within months of introducing pipes, half of the participants sought only smoking supplies. “Not everybody wanted to inject,” emphasized Jim Duffy, the organization’s executive director. This insight reflects a growing recognition of the need to meet users where they are, rather than imposing outdated models of drug use.

Despite the beneficial outcomes associated with smoking, public perception often lags behind evidence-based practices. The Biden administration’s support for distributing “safer smoking kits” has faced criticism, highlighting the ongoing tension between harm reduction strategies and political viewpoints.

The shift in drug consumption patterns underscores the importance of understanding user behavior in the context of public health. As smoking rises in popularity, experts advocate for a more comprehensive approach to harm reduction that includes both smoking and injection strategies.

While many public health advocates view smoking as a safer alternative, they stress that it is not without risks. Concerns remain about the shared use of smoking equipment, which can lead to unintended overdoses among users of different substances. Nevertheless, the consensus among researchers is that promoting smoking as an alternative to injection is a critical intervention.

As Merrill continues her work in harm reduction, she remains committed to meeting the needs of those she serves. Her experience as a former injection drug user fuels her dedication to providing safer options for drug consumption. “We call it safer because you’re not always going to be 100% safe in everything you do, but we can make it safer,” she remarked.

In an era where opioid overdoses still claim over 45,000 lives each year, the evolution of drug consumption methods represents a vital opportunity for public health. Advocates like Merrill emphasize the importance of understanding and supporting user preferences to help reduce harm and save lives.